Literature DB >> 18095950

Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?

S Runge1, J Mayerle, C Warnke, D Robinson, M Roser, S B Felix, S Friesecke.   

Abstract

AIM: We suspect that the life-threatening complication of metformin-associated lactic acidosis, solely due to drug accumulation following renal impairment, occurs more frequently than that previously reported and is not necessarily associated with other predisposing factors for lactic acidosis.
METHODS: During a period of 13 months, at a tertiary referral centre, the incidence of lactic acidosis of any aetiology was 12.8% [67 of 524 total intensive care unit (ICU) admissions]. Metformin-associated lactic acidosis solely as the result of drug accumulation was diagnosed in 6% of all the patients suffering from lactic acidosis (4 of 67 patients).
RESULTS: These patients presented with severe circulatory shock due to lactic acidosis. We could not identify any predisposing factor for lactic acidosis other than renal impairment. Intercurrent deterioration of diabetic nephropathy was suspected to be responsible for the accumulation of metformin followed by lactic acidosis, finally resulting in multiorgan failure. The diagnosis was supported by extensively elevated serum levels of metformin. Two patients died during ICU treatment.
CONCLUSIONS: Our data indicate that the incidence of metformin-associated lactic acidosis solely due to metformin accumulation is possible and underestimated. Symptoms of metformin-associated lactic acidosis are unspecific and physicians should be aware that metformin, if prescribed in patients with renal impairment, can cause fatal lactic acidosis due to drug accumulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095950     DOI: 10.1111/j.1463-1326.2006.00657.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  13 in total

Review 1.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

2.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

3.  Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats.

Authors:  Haiyun Qi; Per M Nielsen; Marie Schroeder; Lotte B Bertelsen; Fredrik Palm; Christoffer Laustsen
Journal:  Diabetologia       Date:  2017-09-21       Impact factor: 10.122

4.  Metformin-related lactic acidosis in patients with acute kidney injury.

Authors:  Vassilios Devetzis; Ploumis Passadakis; Stelios Panagoutsos; Marios Theodoridis; Elias Thodis; Anastasia Georgoulidou; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2010-09-22       Impact factor: 2.370

5.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

6.  Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.

Authors:  Lisbeth V Jacobsen; Charlotte Hindsberger; Richard Robson; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

7.  Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication.

Authors:  Alessandro Protti; Riccarda Russo; Paola Tagliabue; Sarah Vecchio; Mervyn Singer; Alain Rudiger; Giuseppe Foti; Anna Rossi; Giovanni Mistraletti; Luciano Gattinoni
Journal:  Crit Care       Date:  2010-02-19       Impact factor: 9.097

8.  Outcome of severe lactic acidosis associated with metformin accumulation.

Authors:  Sigrun Friesecke; Peter Abel; Markus Roser; Stephan B Felix; Soeren Runge
Journal:  Crit Care       Date:  2010-12-20       Impact factor: 9.097

9.  How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial.

Authors:  Antje Erler; Martin Beyer; Juliana J Petersen; Kristina Saal; Thomas Rath; Justine Rochon; Walter E Haefeli; Ferdinand M Gerlach
Journal:  BMC Fam Pract       Date:  2012-09-06       Impact factor: 2.497

10.  Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2008-09-09       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.